Back to search

National and Kapodistrian University of Athens

Φυτοχημική ανάλυση ιθαγενών ειδών Crepis spp.

Abstract

dc:description

The genus Crepis L. (Asteraceae / Compositae) comprises more than 250 currently recognized species and is distributed throughout the northern hemisphere and Africa, with the Mediterranean area being the most important center of its diversification. Today, less than 10% of the species have been investigated either from a phytochemical or a bioactivity point of view.The genus has been reported rich in sesquiterpene lactones and especially guaianolides, with other terpenoids also being identified, such as triterpenes and sterols. Another widespread group of specialized natural products is phenolics and flavonoids, with predominant compounds being caffeoyl and luteolin derivatives, respectively. The consensus view of specialized herbal metabolites as promising medicinal agents for preventing or managing oxidative stress, inflammation, hyperlipidaemia, and other related disorders, has been shown by their ability to maintain good health and to retard aging processes. Even though phytoconstituents of Crepis genus have been documented, its pharmacological potential has not yet been fully explored. Extracts obtained from various parts of the Crepis spp. and their isolated constituents have undergone limited evaluation as antitumor, anti-inflammatory, antiviral, antimicrobial, antiulcer, antioxidant, and nutritional supplements. Moreover, within the Crepis genus, are few edible representatives, such as C. commutata, C. foetida, C. setosa and C. vesicaria.In this context, nine species were collected from different areas in Greece, specifically Crepis auriculifolia, C. commutata, C. dioscoridis, C. foetida, C. heldreichiana, C. incana, C. rubra, C. sibthorpiana and Phitosia crocifolia (formerly known as Crepis crocifolia). These samples were extracted and further investigated for their chemical profile and their biological effects. It is worth mentioning that among the selected plants Crepis auriculifolia, C. heldreichiana, C. incana, C. sibthorpiana and Phitosia crocifolia account for narrowly endemic types with limited distribution.Phytochemical analysis was conducted via extraction, isolation, and identification of secondary metabolites and qualitative analysis of their extracts aiming to characterize the chemical load of the plants. Selected extracts, fractions, and substances were studied in order to evaluate their cytotoxic, antioxidant, anti-inflammatory, and anti-hyperlipidaemic activity. To determine the constituents of the above-mentioned plant extracts, sample measurements were carried out by using chromatographic techniques (CC, VLC, HPLC, etc), nuclear magnetic resonance (NMR) spectroscopy, liquid chromatography coupled with mass spectrometry (LC- MS), and gas chromatography with mass spectrometry (GC-MS).A total of forty-seven natural products were isolated from Cy-hex:Et2O:MeΟH 1:1:1 and MeOH:H2O 5:1 extracts; twenty-eight components belong to the group of sesquiterpene lactones (1-28), among them with ten new natural products. Sixteen compounds are phenolic derivatives: seven are simple phenolics (32-35,37-39), one caffeoylquinic acid (40) and one is a salicin derivative (36), five are flavonoids (41-45), one is a coumarin derivative (46) and one is a lignan (47). Two triterpenes (29-30) and a nor-isoprenoid (31) were also isolated. In addition, the polar extracts (MeOH:H2O 5:1) of all species were studied through LC-MS and a total of fifty-two components were identified, while the volatile components of the widespread species, C. foetida subsp. foetida, and C. rubra were studied through GC-MS with thirty-nine components being identified.Biological assays:•Volatile fractionWe investigated the volatile fraction of C. foetida flowers (CFA) obtained by hydro-distillation, rich in the salicylic aldehyde, for its anti-inflammatory activity through the inhibition of TNF- α-induced ICAM-1 expression. CFA showed a strong reduction of ICAM-1 expression by 65- 70%, across the range of tested concentrations, without showing any cytotoxic effect.•Cy-hex: Et2O:MeΟH 1:1:1 extractsA.Using the MTT cytotoxicity assay, we investigated the extracts obtained with Cy-hex: Et2O:MeΟH 1:1:1 of the species Crepis auriculifolia, C. commutata, C. incana, C. foetida, C. rubra, C. sibthorpiana and Phitosia crocifolia in human cervical adenocarcinoma cells (HeLa). Moreover, fractions rich in sesquiterpene lactones were selected. The most active fractions showed IC50 from 9.4 to 23.7 µg/mL. Α plant extract is considered to have potent in vitro cytotoxic activity if the IC50 value is less than 20 µg/mL after incubation for 48 and 72 h. Consequently, the studied fractions have strong cytotoxic activity against HeLa cells and could be a potential source of cytotoxic natural products. This was confirmed in the 2nd stage of the experiment, where the pure substances grossheimin (1), 8 epi-grossheimin (2), intergrifolin (4) taraxinic acid (26), phitosin A (13), tanapraetenolide (21), 2-oxo-11-hydroxy-13β-dihydrosandamarin (24), 2β-hydroxysandamarin (17), 8-epi-iso-amberboin (3), 8-epi-isolipididiol (11), integrifolin (4) and 11β,13- dihydro-integrifolin (10) were studied. Among them, substances 4, 26, 1 and 21 showed strong activity with IC50 values of 5.5, 6.5, 9.5 and 10.4 µM, respectively.B.The in vitro metabolism of two sesquiterpene lactones (parthenolide and grossheimin) was analysed using human liver microsomes. More specifically, for parthenolide, five metabolites were found in phase I and in the combined metabolism of phases I and II one glucuronosylated metabolite. For grosheimmin (1), four metabolites were detected in phase I and two metabolites with glucuronic acid in phase II.•MeOH:H2O 5:1 extractsIn addition, we hereby examined the polar extracts, which are more likely to contain polar compounds more relevant to their local use as edible green herbs and also potentially potent antioxidant agents. Thus, the present study further includes a bio-guided approach using antioxidant, anti-inflammatory and hypolipidaemic assays, to unveil the most promising plant extract(s), through both in vitro (Radical Scavenging of DPPH and Total Phenolic Content-Folin Ciocalteu) and in vivo (Paw Oedema Reduction and Hypolipidaemic Activity - experimental mouse protocols) procedures. Initially, the antioxidant activity and the determination of the total polyphenolic content were evaluated in nine samples, from which the most active was selected for further fractionation (C. incana). The resulting fractions were re- evaluated with the same methods, and the next step was to evaluate the extracts and fractions in vivo, in mice models of inflammation and hyperlipidaemia. Among the extracts tested, C. incana presented in vitro the highest gallic acid equivalents (GAE) (0.0834 mg/mL) and the highest antioxidant activity (IC50 = 0.07 mg/mL), as well as the highest anti-inflammatory activity in vivo with 32% paw oedema reduction. Furthermore, in the hypolipidaemic protocol, the same extract increased plasma total antioxidant capacity (TAC) by 48.7% and reduced cholesterol (41.3%), as well as triglycerides (37.2%).

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2022

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Barda, Christina
  • Μπάρδα, Χριστίνα

Subjects

dc:subject × 19

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/52525

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Barda, Christina; Μπάρδα, Χριστίνα. Φυτοχημική ανάλυση ιθαγενών ειδών Crepis spp.. National and Kapodistrian University of Athens, 2022. http://hdl.handle.net/10442/hedi/52525